New drug could reduce severe COVID-19 rates

LONDON: A new treatment has been developed that helps people avoid developing, and aids recovery from, serious cases of COVID-19.
The drug, known as SNG001, has been developed by a team at UK firm Synairgen, and is administered by being inhaled into the body.
SNG001 works by boosting levels of a natural protein, interferon beta-1a, which is known to fight viral infections.